167 related articles for article (PubMed ID: 35954338)
1. Central Lymph Node Ratio Predicts Recurrence in Patients with N1b Papillary Thyroid Carcinoma.
Kang IK; Kim K; Park J; Bae JS; Kim JS
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954338
[TBL] [Abstract][Full Text] [Related]
2. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
[TBL] [Abstract][Full Text] [Related]
3. Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.
Lee SG; Ho J; Choi JB; Kim TH; Kim MJ; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jung SG; Jo YS; Lee J; Chung WY
Medicine (Baltimore); 2016 Feb; 95(5):e2692. PubMed ID: 26844509
[TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.
Rubinstein JC; Dinauer C; Herrick-Reynolds K; Morotti R; Callender GG; Christison-Lagay ER
J Pediatr Surg; 2019 Jan; 54(1):129-132. PubMed ID: 30361076
[TBL] [Abstract][Full Text] [Related]
5. Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma.
Zheng CM; Ji YB; Song CM; Ge MH; Tae K
Clin Exp Otorhinolaryngol; 2018 Mar; 11(1):58-64. PubMed ID: 29032663
[TBL] [Abstract][Full Text] [Related]
6. PROGNOSTIC VALUE OF LYMPH NODE UPTAKE ON PRETREATMENT F-18 FDG PET/CT IN PATIENTS WITH N1B PAPILLARY THYROID CARCINOMA.
Lee CH; Lee SW; Son SH; Hong CM; Jeong JH; Jeong SY; Ahn BC; Lee J
Endocr Pract; 2019 Aug; 25(8):787-793. PubMed ID: 31013158
[No Abstract] [Full Text] [Related]
7. Lymph node ratio predicts recurrence in papillary thyroid cancer.
Schneider DF; Mazeh H; Chen H; Sippel RS
Oncologist; 2013; 18(2):157-62. PubMed ID: 23345543
[TBL] [Abstract][Full Text] [Related]
8. Lymph node ratio as a tool to stratify patients with N1b papillary thyroid cancer.
Luo Z; Hei H; Qin J; Zheng C; Gong W; Zhou B
Langenbecks Arch Surg; 2023 Aug; 408(1):315. PubMed ID: 37584830
[TBL] [Abstract][Full Text] [Related]
9. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
[TBL] [Abstract][Full Text] [Related]
10. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
[TBL] [Abstract][Full Text] [Related]
11. Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.
Kim HI; Kim TH; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim YN; Kim H; Ahn HS; Kim K; Kim SW; Chung JH
Cancer Med; 2017 Oct; 6(10):2244-2251. PubMed ID: 28857489
[TBL] [Abstract][Full Text] [Related]
12. Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma.
Ma T; Cui J; Shi P; Liang M; Song W; Zhang X; Wang L; Shi Y
Front Endocrinol (Lausanne); 2023; 14():1158826. PubMed ID: 37790606
[TBL] [Abstract][Full Text] [Related]
13. Lymph Node Ratio Predicts Recurrence in Patients with Papillary Thyroid Carcinoma with Low Lymph Node Yield.
Kang IK; Park J; Bae JS; Kim JS; Kim K
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296909
[TBL] [Abstract][Full Text] [Related]
14. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection.
Ito Y; Kudo T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2012 Mar; 36(3):593-7. PubMed ID: 22207493
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
[TBL] [Abstract][Full Text] [Related]
16. Cystic Lateral Lymph Node Metastases From Papillary Thyroid Cancer Patients.
Kim JK; Kim MJ; Choi SH; Choi SM; Choi HR; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Laryngoscope; 2020 Dec; 130(12):E976-E981. PubMed ID: 32275332
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer.
Lindfors H; Ihre Lundgren C; Zedenius J; Juhlin CC; Shabo I
World J Surg; 2021 Jul; 45(7):2155-2164. PubMed ID: 33825961
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio is superior to AJCC N stage for predicting recurrence in papillary thyroid carcinoma.
Parvathareddy SK; Siraj AK; Qadri Z; Ahmed SO; DeVera F; Al-Sobhi S; Al-Dayel F; Al-Kuraya KS
Endocr Connect; 2022 Feb; 11(2):. PubMed ID: 35044932
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Nodal US Features for Predicting Recurrence in N1b Papillary Thyroid Carcinoma.
Eun NL; Kim JA; Gweon HM; Youk JH; Son EJ
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008339
[TBL] [Abstract][Full Text] [Related]
20. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
Ryu YJ; Cho JS; Yoon JH; Park MH
World J Surg Oncol; 2018 Oct; 16(1):205. PubMed ID: 30314503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
